ZIVO Reports that USDA Claims Regulatory Jurisdiction for New Coccidiosis Treatment
Regulatory Clarity Enables ZIVO to Focus and Optimize Development Strategy BLOOMFIELD HILLS, Mich.–(BUSINESS WIRE)–ZIVO Bioscience, Inc. (NASDAQ: ZIVO) (the “Company”), a biotech/agtech R&D company engaged in the development of therapeutic, medicinal and nutritional product candidates derived from proprietary algal cultures, announces receipt of a letter from the U.S. Department of Agriculture’s (USDA) Center for Veterinary … [Read more…]